ID   CHST4_HUMAN             Reviewed;         386 AA.
AC   Q8NCG5; Q8IV46; Q9Y5R3;
DT   15-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2005, sequence version 2.
DT   28-JUN-2023, entry version 152.
DE   RecName: Full=Carbohydrate sulfotransferase 4;
DE            EC=2.8.2.- {ECO:0000269|PubMed:10330415, ECO:0000269|PubMed:11439191, ECO:0000269|PubMed:11726653, ECO:0000269|PubMed:12107080};
DE   AltName: Full=Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 3;
DE            Short=GST-3;
DE   AltName: Full=High endothelial cells N-acetylglucosamine 6-O-sulfotransferase;
DE            Short=HEC-GlcNAc6ST;
DE   AltName: Full=L-selectin ligand sulfotransferase;
DE            Short=LSST;
DE   AltName: Full=N-acetylglucosamine 6-O-sulfotransferase 2;
DE            Short=GlcNAc6ST-2;
DE            Short=Gn6st-2;
GN   Name=CHST4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, PATHWAY, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Tonsil;
RX   PubMed=10330415; DOI=10.1083/jcb.145.4.899;
RA   Bistrup A., Bhakta S., Lee J.K., Belov Y.Y., Gunn M.D., Zuo F.-R.,
RA   Huang C.-C., Kannagi R., Rosen S.D., Hemmerich S.;
RT   "Sulfotransferases of two specificities function in the reconstitution of
RT   high endothelial cell ligands for L-selectin.";
RL   J. Cell Biol. 145:899-910(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=11439191; DOI=10.1016/s0092-8674(01)00394-4;
RA   Yeh J.-C., Hiraoka N., Petryniak B., Nakayama J., Ellies L.G., Rabuka D.,
RA   Hindsgaul O., Marth J.D., Lowe J.B., Fukuda M.;
RT   "Novel sulfated lymphocyte homing receptors and their control by a Core1
RT   extension beta 1,3-N-acetylglucosaminyltransferase.";
RL   Cell 105:957-969(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Tonsil;
RX   PubMed=11181564; DOI=10.1093/glycob/11.1.75;
RA   Hemmerich S., Lee J.K., Bhakta S., Bistrup A., Ruddle N.R., Rosen S.D.;
RT   "Chromosomal localization and genomic organization for the galactose/ N-
RT   acetylgalactosamine/N-acetylglucosamine 6-O-sulfotransferase gene family.";
RL   Glycobiology 11:75-87(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=11310842;
RA   Li X., Tu L., Murphy P.G., Kadono T., Steeber D.A., Tedder T.F.;
RT   "CHST1 and CHST2 sulfotransferase expression by vascular endothelial cells
RT   regulates shear-resistant leukocyte rolling via L-selectin.";
RL   J. Leukoc. Biol. 69:565-574(2001).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, TISSUE SPECIFICITY, AND PATHWAY.
RX   PubMed=12107080; DOI=10.1093/glycob/12.6.379;
RA   Seko A., Nagata K., Yonezawa S., Yamashita K.;
RT   "Ectopic expression of a GlcNAc 6-O-sulfotransferase, GlcNAc6ST-2, in
RT   colonic mucinous adenocarcinoma.";
RL   Glycobiology 12:379-388(2002).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, AND PATHWAY.
RX   PubMed=11726653; DOI=10.1074/jbc.m106587200;
RA   Uchimura K., El-Fasakhany F.M., Hori M., Hemmerich S., Blink S.E.,
RA   Kansas G.S., Kanamori A., Kumamoto K., Kannagi R., Muramatsu T.;
RT   "Specificities of N-acetylglucosamine-6-O-sulfotransferases in relation to
RT   L-selectin ligand synthesis and tumor-associated enzyme expression.";
RL   J. Biol. Chem. 277:3979-3984(2002).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12855678; DOI=10.1074/jbc.m304928200;
RA   de Graffenried C.L., Bertozzi C.R.;
RT   "Golgi localization of carbohydrate sulfotransferases is a determinant of
RT   L-selectin ligand biosynthesis.";
RL   J. Biol. Chem. 278:40282-40295(2003).
RN   [10]
RP   SUBUNIT.
RX   PubMed=15220337; DOI=10.1074/jbc.m405709200;
RA   de Graffenried C.L., Bertozzi C.R.;
RT   "The stem region of the sulfotransferase GlcNAc6ST-1 is a determinant of
RT   substrate specificity.";
RL   J. Biol. Chem. 279:40035-40043(2004).
CC   -!- FUNCTION: Sulfotransferase involved in SELL/L-selectin ligand
CC       biosynthesis pathway. Catalyzes the transfer of the sulfate group from
CC       3'-phospho-5'-adenylyl sulfate (PAPS) onto the hydroxyl group at C-6
CC       position of the non-reducing N-acetylglucosamine (GlcNAc) residue
CC       within O-linked mucin-type glycans. Contributes to generate sialyl 6-
CC       sulfo Lewis X determinant (also known as MECA-79 epitope) for SELL
CC       recognition, a prerequisite for continuous lymphocyte homing into
CC       peripheral lymph nodes and antigen immune surveillance
CC       (PubMed:11439191, PubMed:12107080, PubMed:10330415, PubMed:11726653).
CC       Transfers the sulfate group primarily on core 2 GlcNAcbeta1-6(Galbeta1-
CC       3)GalNAcalphaSer/Thr and extended core 1 GlcNAcbeta1-3Galbeta1-
CC       3GalNAcalphaSer/Thr based O-linked glycans on CD34 and GLYCAM1
CC       peripheral node addressins (PNAds) expressed on the lumenal side of
CC       high endothelial venules (HEVs) (PubMed:11439191). The recognition of
CC       PNAds by SELL initiates a multistep process comprising tethering and
CC       rolling of blood lymphocytes on HEVs against the blood flow, followed
CC       by chemokine signaling, integrin-mediated lymphocyte adhesion onto
CC       endothelial cells and lymphocyte transendothelial migration. Modulates
CC       rolling velocity and differential T and B lymphocyte recruitment into
CC       peripheral lymph nodes, with a major role in B lymphocyte homing. Might
CC       be redundant in sulfation of MADCAM1 and lymphocyte trafficking to
CC       mesenteric lymph nodes (By similarity). Can also sulfonate core 3
CC       GlcNAcbeta1-3GalNAc-R based glycans as well as GlcNAcbeta1-3Galbeta1-
CC       Glc, GlcNAcbeta1-6ManOMe and GlcNAcbeta1-2Man oligosaccharides, which
CC       might be ectopically expressed during tumorigenesis (PubMed:12107080,
CC       PubMed:11439191, PubMed:11726653). {ECO:0000250|UniProtKB:Q9R1I1,
CC       ECO:0000269|PubMed:10330415, ECO:0000269|PubMed:11439191,
CC       ECO:0000269|PubMed:11726653, ECO:0000269|PubMed:12107080}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3'-phosphoadenylyl sulfate + 3-O-{N-acetyl-beta-D-
CC         glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-
CC         galactosaminyl}-L-threonyl-[protein] = 3-O-{6-O-sulfo-N-acetyl-beta-
CC         D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-
CC         galactosaminyl}-L-threonyl-[protein] + adenosine 3',5'-bisphosphate +
CC         H(+); Xref=Rhea:RHEA:67856, Rhea:RHEA-COMP:17368, Rhea:RHEA-
CC         COMP:17369, ChEBI:CHEBI:15378, ChEBI:CHEBI:58339, ChEBI:CHEBI:58343,
CC         ChEBI:CHEBI:176489, ChEBI:CHEBI:176492;
CC         Evidence={ECO:0000269|PubMed:11439191};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67857;
CC         Evidence={ECO:0000305|PubMed:11439191};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3'-phosphoadenylyl sulfate + 3-O-{N-acetyl-beta-D-
CC         glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-
CC         galactosaminyl}-L-seryl-[protein] = 3-O-{6-O-sulfo-N-acetyl-beta-D-
CC         glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-
CC         galactosaminyl}-L-seryl-[protein] + adenosine 3',5'-bisphosphate +
CC         H(+); Xref=Rhea:RHEA:67860, Rhea:RHEA-COMP:17365, Rhea:RHEA-
CC         COMP:17366, ChEBI:CHEBI:15378, ChEBI:CHEBI:58339, ChEBI:CHEBI:58343,
CC         ChEBI:CHEBI:176490, ChEBI:CHEBI:176491;
CC         Evidence={ECO:0000269|PubMed:11439191};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67861;
CC         Evidence={ECO:0000305|PubMed:11439191};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3'-phosphoadenylyl sulfate + 3-O-{beta-D-galactosyl-(1->3)-[N-
CC         acetyl-beta-D-glucosaminyl-(1->6)]-N-acetyl-alpha-D-galactosaminyl}-
CC         L-threonyl-[protein] = 3-O-{beta-D-galactosyl-(1->3)-[6-O-sulfo-N-
CC         acetyl-beta-D-glucosaminyl-(1->6)]-N-acetyl-alpha-D-galactosaminyl}-
CC         L-threonyl-[protein] + adenosine 3',5'-bisphosphate + H(+);
CC         Xref=Rhea:RHEA:67864, Rhea:RHEA-COMP:14420, Rhea:RHEA-COMP:17370,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:58339, ChEBI:CHEBI:58343,
CC         ChEBI:CHEBI:139607, ChEBI:CHEBI:176493;
CC         Evidence={ECO:0000269|PubMed:10330415, ECO:0000269|PubMed:11439191,
CC         ECO:0000269|PubMed:11726653, ECO:0000269|PubMed:12107080};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67865;
CC         Evidence={ECO:0000305|PubMed:10330415, ECO:0000305|PubMed:11439191,
CC         ECO:0000305|PubMed:11726653, ECO:0000305|PubMed:12107080};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3'-phosphoadenylyl sulfate + 3-O-{beta-D-galactosyl-(1->3)-[N-
CC         acetyl-beta-D-glucosaminyl-(1->6)]-N-acetyl-alpha-D-galactosaminyl}-
CC         L-seryl-[protein] = 3-O-{beta-D-galactosyl-(1->3)-[6-O-sulfo-N-
CC         acetyl-beta-D-glucosaminyl-(1->6)]-N-acetyl-alpha-D-galactosaminyl}-
CC         L-seryl-[protein] + adenosine 3',5'-bisphosphate + H(+);
CC         Xref=Rhea:RHEA:67868, Rhea:RHEA-COMP:14419, Rhea:RHEA-COMP:17367,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:58339, ChEBI:CHEBI:58343,
CC         ChEBI:CHEBI:139605, ChEBI:CHEBI:176494;
CC         Evidence={ECO:0000269|PubMed:10330415, ECO:0000269|PubMed:11439191,
CC         ECO:0000269|PubMed:11726653, ECO:0000269|PubMed:12107080};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67869;
CC         Evidence={ECO:0000305|PubMed:10330415, ECO:0000305|PubMed:11439191,
CC         ECO:0000305|PubMed:11726653, ECO:0000305|PubMed:12107080};
CC   -!- PATHWAY: Protein modification; carbohydrate sulfation.
CC       {ECO:0000269|PubMed:10330415, ECO:0000269|PubMed:11439191,
CC       ECO:0000269|PubMed:11726653, ECO:0000269|PubMed:12107080}.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:15220337}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000269|PubMed:12855678}; Single-pass type II membrane protein
CC       {ECO:0000269|PubMed:12855678}.
CC   -!- TISSUE SPECIFICITY: Specifically expressed in HEV. Weakly expressed in
CC       spleen. Not expressed in other tissues. Expressed in colonic mucinous
CC       adenocarcinoma. {ECO:0000269|PubMed:10330415,
CC       ECO:0000269|PubMed:11310842, ECO:0000269|PubMed:12107080}.
CC   -!- INDUCTION: Upon cytokine activation, it is expressed at low level.
CC       {ECO:0000269|PubMed:11310842}.
CC   -!- MISCELLANEOUS: May serve as an anti-inflammatory target.
CC   -!- SIMILARITY: Belongs to the sulfotransferase 1 family. Gal/GlcNAc/GalNAc
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH35282.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF131235; AAD33015.1; -; mRNA.
DR   EMBL; AF149783; AAK48417.1; -; mRNA.
DR   EMBL; AF280088; AAG48246.1; -; mRNA.
DR   EMBL; AK074746; BAC11177.1; -; mRNA.
DR   EMBL; BC035282; AAH35282.1; ALT_INIT; mRNA.
DR   CCDS; CCDS10902.1; -.
DR   RefSeq; NP_001159867.1; NM_001166395.1.
DR   RefSeq; NP_005760.1; NM_005769.2.
DR   AlphaFoldDB; Q8NCG5; -.
DR   BioGRID; 115466; 4.
DR   IntAct; Q8NCG5; 2.
DR   STRING; 9606.ENSP00000341206; -.
DR   ChEMBL; CHEMBL2239; -.
DR   GlyCosmos; Q8NCG5; 3 sites, No reported glycans.
DR   GlyGen; Q8NCG5; 3 sites.
DR   iPTMnet; Q8NCG5; -.
DR   PhosphoSitePlus; Q8NCG5; -.
DR   BioMuta; CHST4; -.
DR   DMDM; 61211834; -.
DR   EPD; Q8NCG5; -.
DR   MassIVE; Q8NCG5; -.
DR   PaxDb; Q8NCG5; -.
DR   PeptideAtlas; Q8NCG5; -.
DR   ProteomicsDB; 72890; -.
DR   Antibodypedia; 16600; 112 antibodies from 22 providers.
DR   DNASU; 10164; -.
DR   Ensembl; ENST00000338482.5; ENSP00000341206.5; ENSG00000140835.10.
DR   Ensembl; ENST00000539698.4; ENSP00000441204.3; ENSG00000140835.10.
DR   GeneID; 10164; -.
DR   KEGG; hsa:10164; -.
DR   MANE-Select; ENST00000539698.4; ENSP00000441204.3; NM_001166395.2; NP_001159867.1.
DR   UCSC; uc002fan.4; human.
DR   AGR; HGNC:1972; -.
DR   CTD; 10164; -.
DR   DisGeNET; 10164; -.
DR   GeneCards; CHST4; -.
DR   HGNC; HGNC:1972; CHST4.
DR   HPA; ENSG00000140835; Tissue enriched (gallbladder).
DR   neXtProt; NX_Q8NCG5; -.
DR   OpenTargets; ENSG00000140835; -.
DR   PharmGKB; PA26504; -.
DR   VEuPathDB; HostDB:ENSG00000140835; -.
DR   eggNOG; ENOG502RGC5; Eukaryota.
DR   GeneTree; ENSGT00940000162746; -.
DR   HOGENOM; CLU_028381_3_1_1; -.
DR   InParanoid; Q8NCG5; -.
DR   OMA; AWHIWMT; -.
DR   OrthoDB; 3031241at2759; -.
DR   PhylomeDB; Q8NCG5; -.
DR   TreeFam; TF342871; -.
DR   PathwayCommons; Q8NCG5; -.
DR   Reactome; R-HSA-913709; O-linked glycosylation of mucins.
DR   SABIO-RK; Q8NCG5; -.
DR   SignaLink; Q8NCG5; -.
DR   UniPathway; UPA00353; -.
DR   BioGRID-ORCS; 10164; 13 hits in 1147 CRISPR screens.
DR   GeneWiki; CHST4; -.
DR   GenomeRNAi; 10164; -.
DR   Pharos; Q8NCG5; Tbio.
DR   PRO; PR:Q8NCG5; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; Q8NCG5; protein.
DR   Bgee; ENSG00000140835; Expressed in gall bladder and 62 other tissues.
DR   Genevisible; Q8NCG5; HS.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0005802; C:trans-Golgi network; IDA:UniProtKB.
DR   GO; GO:0001517; F:N-acetylglucosamine 6-O-sulfotransferase activity; IDA:UniProtKB.
DR   GO; GO:0008146; F:sulfotransferase activity; TAS:ProtInc.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0007267; P:cell-cell signaling; TAS:ProtInc.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0006044; P:N-acetylglucosamine metabolic process; IDA:UniProtKB.
DR   GO; GO:0016266; P:O-glycan processing; TAS:Reactome.
DR   GO; GO:1903238; P:positive regulation of leukocyte tethering or rolling; ISS:UniProtKB.
DR   GO; GO:0006477; P:protein sulfation; IBA:GO_Central.
DR   GO; GO:0006790; P:sulfur compound metabolic process; IDA:UniProtKB.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR016469; Carbohydrate_sulfotransferase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR000863; Sulfotransferase_dom.
DR   PANTHER; PTHR10704; CARBOHYDRATE SULFOTRANSFERASE; 1.
DR   PANTHER; PTHR10704:SF40; CARBOHYDRATE SULFOTRANSFERASE 4; 1.
DR   Pfam; PF00685; Sulfotransfer_1; 1.
DR   PIRSF; PIRSF005883; Carbohydrate_sulfotransferase; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
PE   1: Evidence at protein level;
KW   Carbohydrate metabolism; Glycoprotein; Golgi apparatus;
KW   Inflammatory response; Membrane; Reference proteome; Signal-anchor;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN           1..386
FT                   /note="Carbohydrate sulfotransferase 4"
FT                   /id="PRO_0000085193"
FT   TOPO_DOM        1..7
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        8..28
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        29..386
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   BINDING         51..57
FT                   /ligand="3'-phosphoadenylyl sulfate"
FT                   /ligand_id="ChEBI:CHEBI:58339"
FT                   /evidence="ECO:0000250"
FT   BINDING         205..213
FT                   /ligand="3'-phosphoadenylyl sulfate"
FT                   /ligand_id="ChEBI:CHEBI:58339"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        30
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        308
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        329
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VARIANT         361
FT                   /note="H -> Q (in dbSNP:rs3813744)"
FT                   /id="VAR_052528"
FT   CONFLICT        225
FT                   /note="S -> N (in Ref. 4; BAC11177)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   386 AA;  45134 MW;  0C3BB4022417143A CRC64;
     MLLPKKMKLL LFLVSQMAIL ALFFHMYSHN ISSLSMKAQP ERMHVLVLSS WRSGSSFVGQ
     LFGQHPDVFY LMEPAWHVWM TFKQSTAWML HMAVRDLIRA VFLCDMSVFD AYMEPGPRRQ
     SSLFQWENSR ALCSAPACDI IPQDEIIPRA HCRLLCSQQP FEVVEKACRS YSHVVLKEVR
     FFNLQSLYPL LKDPSLNLHI VHLVRDPRAV FRSRERTKGD LMIDSRIVMG QHEQKLKKED
     QPYYVMQVIC QSQLEIYKTI QSLPKALQER YLLVRYEDLA RAPVAQTSRM YEFVGLEFLP
     HLQTWVHNIT RGKGMGDHAF HTNARDALNV SQAWRWSLPY EKVSRLQKAC GDAMNLLGYR
     HVRSEQEQRN LLLDLLSTWT VPEQIH
//
